About Refuge Biotechnologies

Refuge is a cancer immunotherapy company leveraging synthetic biology and gene engineering to unlock the full promise of cell therapies. We create cell therapies that sense their surroundings and conditionally activate or repress multiple genes simultaneously – resulting in more potent and targeted treatments beyond a single target and function.

Company Highlights
Year Founded

2015

icon-altEmployees

4

Location (HQ)

USA

Since Last Funding

6 years 4 months

Monthly Website Visitors

248

icon-altTotal Investment Amt

$34M

Last Funding Round

Series B

icon-altYoY Headcount Growth

-19.61%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Health Care

Biotechnology

Biotechnology Research

Therapeutics

Genetics